Background

After the trips to Singapore (2015, 2016), Israel (2017), Denmark (2018), and Canada (2019) the destination of the study trip 2022 is Estland.

Program
A total of six study half-days are planned (theory and visits to institutions). The program will be available soon.

• Introduction into the health system
• Visits of hospitals
• Insurance companies
• Pharmaceutical industry

The detailed program will be available by the end of January 2023. It includes an overview of the Estonian healthcare system where digitalization has been establishes since more than ten years. E-prescriptions and electronic patient dossiers are mandatory and video consultations and remote diagnoses have been integrated into outpatient care.

Download Brochure »»

Participants

The study trip is intended for all experts working in public healthcare services. Minimum number of participants: 12 - 15 persons.

Credits

The trip provides 3 ECTS credits (rewarded after assignment has been accepted)

Study Trip Fees

Price varies according to country, registration and management via Max Künzi, 10% rebate for ECPM students. We reserve the right to change the program and/or the prices anytime.

Registration

For more information and registration please contact max.kuenzi@sagg-sahe.ch

Contact

Lic. iur. Max Künzi, MM | SAGG/SAHE | c/o Künzi Beratungen | Schachenstrasse 21 | Postfach 201 | 4702 Oensingen T (+41)(0)62 396 10 49 | F (+41)(0)62 396 24 10 | max.kuenzi@sagg-sahe.ch | www.sagg-sahe.ch | in cooperation with a travel agency.

Course Description

Genomics in Drug Development is a specific and debated approach tailored to the individual patient’s genome.
Because of the high cost of failures, insights that increase the probability of success of bringing a drug program to approval are critical to boost the productivity and efficiency of drug development. It has been proposed that using germline human genetics to drive drug discovery can overcome some of these issues. Drug targets with underlying human genetic support linked to their indication are 2-fold more likely to gain approval in the United States and European Union as compared with drug targets without human genetic support.

To get to the point where Using Genetics and Genomics in Drug Discovery, Drug Development and further in Clinical Development can be achieved, there have to be set and defined regulations and addressed different questions regarding Ethical, Legal and Social Aspects as well as Data Safety and Data Protection.

How far can we go? What is and can be ethically, legally and socially accepted? What about Genetics and Genomics in the evaluation of drug safety and where is the data stored safely? How is the intercultural, international and even further the intercontinental handling of the regulations and safety evaluation? How to handle Epidemiologic and Public Health related questions and how to deal with Genetics and Genomics in the future will be part of the Course and will be discussed and brought to the table.

This Course brings together thought leaders and well-renowned experts from industry and academia. We will illuminate the topic in various ways, which allows you to get a deep insight to Genomics in Drug Development and a better understanding of its complexity.

Join us on June 7 & 8, 2023 to learn from and discuss with the experts!

Course Program

Day 1
Basics of Genetics / Genetic Testing Networks / Genetic Epidemiology and Public Health Genetics / Using Genetics and Genomics for Target Identification and Drug Discovery

Day 2
Using Genetics and Genomics in Clinical Development / Treatment of Genetic Diseases incl. Gene-Therapy / Genetics and Genomics in Drug Safety Evaluation / Ethical, Legal and Social Aspects incl. Data Protection Aspects

Learning Outcomes

By the end of the course, students will be able to:

• understand Genetic Epidemiology and Public Health Genetics
• know how Genetics and Genomics are used for Target Identification, Drug Discovery, in Clinical Development and in the Treatment of Genetic Diseases
• have an overview of Genetics and Genomics in Drug Safety Evaluation
• see the importance of Ethical, Legal and Social Aspects incl. Data Protection Aspects

Course Faculty

Tba

Target Audience

All pharmaceutical and health care professionals who are interested in getting a deeper understanding of genomics in medicines development.

Course Language

English

Course Credits and Certificate

Participation and submission of assignment result in a Certificate of Attendance by the University of Basel with 1 ECTS credit point and is also accredited with 100 FPH-points in hospital pharmacy and 100 FPH-points in clinical pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

Course Date and Venue

Basel, 7 & 8 June, 2023
University of Basel, Biozentrum, Spitalstrasse 41, 4056 Basel, Switzerland

Course Fee

Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 1950.
The reduced for participants from academia and nonprofit organizations is CHF 950.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

May 22, 2023

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This course is an intense two-day interactive, hands-on program designed to build and expand essential presentation skills from both content and delivery perspectives. Participants will learn how to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Participants should come ready to deliver a ten-minute presentation as well as a short story about a project in which they have been involved. Crucially, the story must include the type of obstacles that were faced, how they were overcome, the people or factors that helped or hindered along the way, together with the successes and failures and the outcome. Feedback from peers and the facilitators will help participants improve their ability to connect from both content and delivery perspectives.

Course Program

Day 1 – The process, establishing a baseline, stakeholders and messaging

• Introduction to developing powerful presentations
• Participants will deliver two presentations and receive direct feedback
• Stakeholder definition, prioritization and analysis
• Development of key messages

Day 2 – Storytelling, creating a narrative, and Q&A

• Storytelling techniques
• Structure and storyboard a presentation to address key stakeholders
• Media techniques to confidently handle question and answer sessions
• Delivery of final presentations by participants

Learning Outcomes

By the end of the course, participants will have a better understanding of how to:

• Present in a more compelling way to internal and external stakeholders with increased confidence and capability
• Use skills and techniques to:
  • Translate complex concepts into scalable and tailored messages for stakeholders
  • Develop engaging narratives using storytelling models that showcase and differentiate their science/project
  • Speak effectively to groups of any size face-to-face and online
  • Confidently handle question and answer sessions

Course Faculty

O’Patrick Wilson and Jennifer Sgueglia, O public relations GmbH, Ettingen, Switzerland

Target Audience

The course is designed for participants who want to improve their personal communication skills, their ability to develop targeted, compelling and memorable presentations, and to handle difficult questions from stakeholders.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits and a Certificate of Attendance by the University of Basel will be issued. The course is accredited with 100 FPH-points in hospital pharmacy by the Swiss Society FPH Spital (Fachgesellschaft FPH Spital).

Course Date and Venue

June 27–28, 2023
University of Basel

Course Fee

Course fee including certificate, electronic course material, lunch and coffee break is CHF 1800.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

June 12, 2023

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Join courses run by our partner universities in the European University Network, which offer training relevant to drug development sciences and the IMI PharmaTrain syllabus. For an overview of all PharmaTrain Recognized Course Providers please click here.

Course Description

Brush up your scientific and medical writing skills. Learn how to structure scientific papers and reports and write a clear and informative scientific text. This course provides a comprehensive overview of the strategic scientific and medical writing field and offers hands-on training in writing and analyzing scientific texts.

Course Program

This course will cover:

• What is the correct strategic approach to writing successful documents
• How to convey a message to the target audience
• How to produce high-quality documents
• What are the requirements to reach a successful outcome
• Ethics of scientific writing
• Practical work with multiple exercises

Learning Outcomes

By the end of the course, students will be able to:

• Know key elements of good medical and scientific writing
• Critically appraise texts and identify elements of poor writing
• Convert some examples of poor writing to good scientific writing
• Reproduce the most important aspects of good medical and scientific writing
• Improve own texts

Course Faculty

Dr. Silvia M. Rogers, MEDIWRITE, Basel, Switzerland

Target Audience

This course is for all professionals (native or non-native English speakers) who intend to improve their scientific medical writing skills.

Course Language

English

Course Credits

The course including homework provides 1 ECTS credit and a Certificate of Attendance by the University of Basel will be issued.
100 FPH credit points in hospital pharmacy (accreditation to be submitted)

Course Date and Venue

06.11.– 07.11.2023
University of Basel

Course Fee

Course fee including certificate, electronic course material and book by Silvia Rogers is 1000 CHF.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

20.10.2023

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

The implementation of clinical research projects requires conscientious review of research projects not only in terms of their scientific quality but also in regard to their ethical adequacy and appropriateness. How can we balance the risk-benefit of our projects? Given the importance of ethics for the conduct of drug development and research, it should come as no surprise that many different professional associations, government agencies, and universities have adopted specific codes, rules, and policies relating to research ethics.

Each of these aspects will be carefully considered and discussed in the context of international and national principles and guidelines. These issues need to be carefully adhered to strengthen the health of the clinical trial enterprise to the benefit of patients and the overall health of the public. During our course, representatives from different institutions will introduce and discuss the most important concepts, tools, principles, and methods that can be useful in approaching and resolving ethical dilemmas. Realworld examples and case studies will be introduced and discussed.

Course Program

Day 1
The Evolution of Biomedical Research Ethics / Risk-Benefit Considerations of Research Interventions / Role of Ethics Committees / Successful Submission to an Ethics Committee / Coordinating Human Research in Switzerland / How to Design an Informed Consent / Ethical Review Systems in Europe and European Legislation / Ethics Committees’ Role in Reviewing Safety Information

Day 2
Equipoise / Transparency in Clinical Trials / Common Technical Document / Confidentiality and Intellectual Property / Personal Data Protection / Inducement in Clinical Research – from Recruitment Advertisement to Subject Compensation / Role of Patient Organisations in Clinical Trials (EUPATI) / Public Health Ethics (incl. biobanks)

Day 3
Ethical Aspects of Clinical Research in Children / Informed Consent Process in Pediatric Patients / Clinical Research in Vulnerable Populations / Misconduct and Fraud, Research Integrity / ICH E6 Regulation / Legal and Ethical Framework for Genetic Testing

Learning Outcomes

By the end of the course, students will be able to:

• Name key principles of ethical considerations during clinical research and development
• Discuss ethical concerns for designing, conducting and reporting the results obtained through the conduct of clinical trials
• Understand international and national principles and guidelines which have to be followed when performing clinical trials

Course Faculty

tba

Target Audience

All pharmaceutical and health care professionals who are interested in getting a deeper understanding of ethical and legal aspects in medicines development.

Course Language

English

Course Credits

The course including assessment provides 2 ECTS credits and a Certificate of Attendance by the University of Basel will be issued.

Course Date and Venue

Basel, 4–6 November, 2024
University of Basel

Course Fee

Course fee including certificate, electronic course material, lunch and coffee breaks is CHF 2000.
A reduced fee applies to participants from academia and nonprofit organizations.

Cancellation Policy

Refund of fee will be given if cancellation is received in written format (ecpm@unibas.ch) before the deadline for registration, after this date no refund can be given.

Deadline for Registration

October 11, 2024

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This e-learning course provides an understanding of the key principles and methodological concepts of health economic evaluations. It is based on the well-established face-to-face course on health economics offered by the ECPM. The scientific content was developed by Prof. Thomas Szucs and Prof. Matthias Schwenkglenks as well as other specialists from the field.

Learning Outcomes

At the end of the course, the participants should be able to describe:

• Fundamental concepts of health economics
• Key elements of health economic evaluation
• Assessment and analysis of a published health economic study
• The importance of health economic/pharmacoeconomic methods and concepts for the drug development process, clinical trials, and post-marketing surveillance
• How policymakers set priorities in health care and how health economic evaluations support this process

Structure and Workload

Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

Course Language

English

Course Credits

After successful completion of the e-learning course, 1 ECTS will be awarded and a Certificate of Attendance by the University of Basel will be issued.

Course Fee

CHF 650
A reduced fee applies to participants from academia and nonprofit organizations.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This e-learning course provides an understanding of the safety-related aspects within the drug development process. These range from early preclinical testing, risk/benefit assessment up to clinical adverse event signal detection and monitoring.

Learning Outcomes

At the end of the course, the participants should be able to describe:

• The role of drug safety in the successful development and usage of a medicine to the benefit of patients
• Which safety-related questions need to be answered in early and late drug development
• Tools, techniques, and methodologies used in drug safety evaluation
• What frequent pitfalls related to drug safety considerations occur and why they can lead to discontinuation of drugs in development, label changes or even withdrawal of drugs from the market after launch
• How changes in safety assessment could become part of a new drug development paradigm

Structure and Workload

Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition, individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

Course Language

English

Course Credits

After successful completion of the e-learning course, 1 ECTS will be awarded and a Certificate of Attendance by the University of Basel will be issued.

Course Fee

CHF 650
A reduced fee applies to participants from academia and nonprofit organizations.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.

Course Description

This e-learning course provides an understanding of the key principles and methodological concepts of personalized drug development. The role of individualized treatment strategies is addressed, including all relevant clinical, ethical and governmental aspects.

Learning Outcomes

At the end of the course, the participants should be able to:

• Understand the biological and clinical concepts of personalized medicine
• Understand the benefits and pitfalls of individualized therapies for patients
• Comprehend the basic elements of predictive and prognostic interventions
• Understand the role of surrogate endpoints and clinically validated biomarkers in personalized medicine
• Understand pharmacogenetic and pharmacogenomic implications
• Be aware of the strategies of R&D processes with personalized drugs
• Understand the economics challenges of personalized medicine and how policymakers set priorities in individualized health care
• Determine legal, regulatory and ethical aspects of personalised medicine

Structure and Workload

Our e-learning courses provide an interactive environment for self-paced learning. As soon as you have booked the course, the program is accessible online for you during one year at anytime. The course allows you to start/stop at any time. There will be several intermediate tests which will prepare you for the final test. The curriculum consists of nine lessons with a duration of approximately 60 to 90 minutes each. In addition individual study, such as critical appraisal of specific literature is required (in total: approximately 30 hours). Each lesson is aimed to achieve a set of learning outcomes, using interactive techniques to help reinforce the taught topics.

Course Language

English

Course Credits

After successful completion of the e-learning course, 1 ECTS will be awarded and a Certificate of Attendance by the University of Basel will be issued.

Course Fee

CHF 650
A reduced fee applies to participants from academia and nonprofit organizations.

Course Organizer

This course is organized by the European Center of Pharmaceutical Medicine.